Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Denlinger, CS; Sanft, T; Baker, KS; Broderick, G; Demark-Wahnefried, W; Friedman, DL; Goldman, M; Hudson, M; Khakpour, N; King, A; Koura, D ...
Published in: Journal of the National Comprehensive Cancer Network : JNCCN
October 2018
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of the National Comprehensive Cancer Network : JNCCN
DOI
EISSN
1540-1413
ISSN
1540-1405
Publication Date
October 2018
Volume
16
Issue
10
Start / End Page
1216 / 1247
Related Subject Headings
- Virus Diseases
- Vaccination
- United States
- Survivorship
- Societies, Medical
- Risk Assessment
- Oncology & Carcinogenesis
- Neoplasms
- Medical Oncology
- Mass Screening
Citation
APA
Chicago
ICMJE
MLA
NLM
Denlinger, C. S., Sanft, T., Baker, K. S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., … Freedman-Cass, D. A. (2018). Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 16(10), 1216–1247. https://doi.org/10.6004/jnccn.2018.0078
Denlinger, Crystal S., Tara Sanft, K Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, et al. “Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.” Journal of the National Comprehensive Cancer Network : JNCCN 16, no. 10 (October 2018): 1216–47. https://doi.org/10.6004/jnccn.2018.0078.
Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, et al. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Oct;16(10):1216–47.
Denlinger, Crystal S., et al. “Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.” Journal of the National Comprehensive Cancer Network : JNCCN, vol. 16, no. 10, Oct. 2018, pp. 1216–47. Epmc, doi:10.6004/jnccn.2018.0078.
Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Oct;16(10):1216–1247.
Published In
Journal of the National Comprehensive Cancer Network : JNCCN
DOI
EISSN
1540-1413
ISSN
1540-1405
Publication Date
October 2018
Volume
16
Issue
10
Start / End Page
1216 / 1247
Related Subject Headings
- Virus Diseases
- Vaccination
- United States
- Survivorship
- Societies, Medical
- Risk Assessment
- Oncology & Carcinogenesis
- Neoplasms
- Medical Oncology
- Mass Screening